RecruitingObstructive Sleep Apnea of AdultPreeclampsiaObstetrical Complications
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
Eligible age
18+ yrs
Accepts
Women
Locations
10 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate of hypertensive disorders of pregnancy.
Sponsor: The George Washington University Biostatistics Center
You may qualify if…
- ✓ 1. Singleton gestation. Twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age.
- ✓ 2. Gestational age at randomization between 14 weeks 0 days and 21 weeks 6 days based on clinical information and evaluation of the earliest ultrasound.
- ✓ 3. Diagnosis with mild to moderate OSA as defined by an AHI score ≥ 5 and \<30.
You may not qualify if…
- ✕ 1. Previously prescribed, current or planned therapy for sleep apnea.
- ✕ 2. Age \< 18 years, because the rate of sleep apnea in this population is extremely low.
- ✕ 3. Inability to sleep in a stable place with access to the CPAP machine at least 5 nights per week.
- ✕ 4. Asthma requiring systemic steroid therapy for more than 14 days within the past 6 months because this population is expected to be unresponsive to CPAP therapy.
- ✕ 5. Current use of prescribed sleeping pills for insomnia.
- ✕ 6. Chronic medical conditions requiring oxygen supplementation (e.g. pulmonary fibrosis, pulmonary hypertension, cystic fibrosis) because this population is expected to be unresponsive to CPAP therapy.
- ✕ 7. Chronic renal disease with serum creatinine \>1.3 mg/dL because the primary outcome would be pre-determined.
- ✕ 8. Antiphospholipid antibody syndrome, because it would compromise the primary outcome diagnosis.
Where it's recruiting
Alabama
Birmingham
California
San Francisco
Illinois
Chicago
New York
New York
North Carolina
Chapel Hill
Ohio
Cleveland · Columbus
Pennsylvania
Philadelphia · Pittsburgh
Rhode Island
Providence
Texas
Galveston · Houston
Utah
Salt Lake City
Source: ClinicalTrials.gov · NCT03487185 · last updated 2026-04-06